Market Tracker

10/30 12:37pm ET
12.35
Real-Time Quote
 +0.61 / +5.20%
Today’s Change
6.05
Today|||52-Week Range
12.33
+63.90%
Year-to-Date

Today’s Trading

Previous close11.74
Today’s open11.61
Day’s range11.55 - 12.33
Volume428,054
Average volume (3 months)987,088
Market cap$1.6B
Dividend yield--
Data as of 12:21pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)+13.33%
Earnings growth (this year)+56.04%
Earnings growth (next 5 years)-90.73%
Revenue growth (last year)-1.32%
P/E ratioNM
Price/Sales15.17
Price/Book54.28

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.19+1.16%
NKTRNektar Therapeutics+0.25+1.80%
ABCOAdvisory Board Co+0.63+1.20%
ARIAARIAD Pharmaceutical...+0.05+0.85%
Data as of 12:36pm ET, 10/30/2014

Financials

Next reporting dateFebruary 18, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$53.9M
Annual profit (last year)-$27.8M
Net profit margin-51.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts